OGN
Organon & Co. · Healthcare · Market cap $3.6B
Insiders sold $200K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Aug 5, 2026
Insider Buying
$855K
reported purchases (SEC code P)
Insider Selling
$553K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Aug 12, 2026
Drinane Juliana Papa
Organon & Co. (OGN) has 36 SEC Form 4 filings (98 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 12, 2026.
Inside the rolling window, 3 insiders at Organon & Co. reported 2 open-market purchases totaling $855K and 2 open-market sales totaling $553K. Insiders have net sold $200K over the trailing 6 months. The most recent open-market filing is a sale of 14,761 shares by Head of Mfg & Supply Drinane Juliana Papa, dated Aug 5, 2026, worth $200K.
- Industry:Drug Manufacturers - General
- CEO:Joseph T. Morrissey Jr.
- Employees:10,000
- HQ:Jersey City, NJ, US
- IPO:2021-05-14
| Source | |||||||
|---|---|---|---|---|---|---|---|
Drinane Juliana PapaFirst filing | Head of Mfg & Supply | Sale | 14,761 | $200K | Aug 5 | +1.3% | SEC ↗ |
| SVP and Corporate Controller | Sale | 26,448.366 | $353K | May 7 | +3.2% | SEC ↗ | |
Holzbaur LynetteFirst filing | SVP and Corporate Controller | Purchase | 26,448.366 | $353K | May 7 | +3.2% | SEC ↗ |
COX CARRIE SMITHFirst filing | Executive Chair | Purchase | 65,400 | $502K | Nov 13 | +80.4% | SEC ↗ |
Congress trading OGN 35 all-time
- RRep. Kevin HernSale$1,001 - $15,0002026-08-05
- RRep. Kevin HernSale$1,001 - $15,0002026-08-05
- DSen. Gary C. PetersSale$1,001 - $15,0002025-10-07
- DSen. Gary C. PetersOther$1,001 - $15,0002025-07-10
- DRep. Ro KhannaSale$1,001 - $15,0002023-11-03
- DRep. Ro KhannaPurchase$1,001 - $15,0002023-10-02
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does OGN have?
Organon & Co. (OGN) has 36 SEC Form 4 filings (98 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Aug 12, 2026.
When was the most recent SEC Form 4 filing for OGN?
The most recent Form 4 filing for OGN on Tracefour is dated Aug 12, 2026.
What is the net insider flow at OGN over the last 6 months?
Over the trailing 180 days, insiders at OGN have net sold $200K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at OGN in the current window?
Inside the rolling window, insiders at OGN bought $855K and sold $553K based on SEC Form 4 filings.
Can I get alerts for OGN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Organon & Co. (OGN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Organon & Co. is in the Healthcare sector.